GlaxoSmithKline (GSK) Tops Q2 EPS by 4c
Tweet
Share
E-mail
Get Alerts GSK Hot Sheet
Join SI Premium – FREE
GlaxoSmithKline (NYSE: GSK) reported Q2 EPS of GBP0.25, GBP0.04 better than the analyst estimate of GBP0.21. Revenue for the quarter came in at GBP6.35 billion versus the consensus estimate of GBP6.34 billion.
For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- FOMC minutes from July 28-29th meeting
- Target raises full-year sales forecast amid ongoing turnaround drive
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
